Liver function in acute viral hepatitis as determined by a hepatocyte‐specific ligand: 99mTc‐galactosyl–neoglycoalbumin
Irene Virgolini, Christian Müller, Josef Höbart, Werner Scheithauer, Peter Angelberger, Helmar Bergmann, John O'Grady, Helmut Sinzinger – 1 April 1992 – Twelve patients with recently diagnosed acute viral hepatitis underwent serial 99mTc‐galactosyl neoglycoalbumin scanning of the liver (for up to 8 mo). Injection of 99mTc‐galactosyl neoglycoalbumin (150 mBq) at a rate of 3.5 mg (50 nmol; 1 ml) revealed that the liver is the exclusive site of tracer uptake.